BackBetter Therapeutics- Tradeable Rights - March 2021 Overview

Better Therapeutics- Tradeable Rights - March 2021 Current Cash

Track Better Therapeutics- Tradeable Rights - March 2021's current cash ($6.6M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$6.60M
↓ 70.42% YoYΔ $-15.71M vs prior year quarter

Peer trimmed avg / median

Loading

Better Therapeutics- Tradeable Rights - March 2021 Current Cash History

Loading

Better Therapeutics- Tradeable Rights - March 2021 vs. peers: Current Cash Comparison

Loading

Better Therapeutics- Tradeable Rights - March 2021 Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Better Therapeutics- Tradeable Rights - March 2021 (MCADR) FAQ

As of the most recent data (September 2023), MCADR shows a current cash of $6.6M. That compares with $22M in the prior-year period — down 70.4% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, MCADR's current cash is now $6.6M (was $22M) — a 70.4% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Better Therapeutics- Tradeable Rights - March 2021 is outperforming or lagging.

Tracking MCADR's current cash over time shows whether Better Therapeutics- Tradeable Rights - March 2021 is scaling, shrinking, or reshaping that part of the business. The current reading is $6.6M That compares with $22M in the prior-year period — down 70.4% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current cash page, Stockcircle has Better Therapeutics- Tradeable Rights - March 2021's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $6.6M) with ownership activity and broader fundamentals.